— CATEGORY · 2 COMPOUNDS

Growth research peptides

Growth hormone-releasing hormone (GHRH) analogues studied in preclinical and clinical research for their effects on GH secretion, IGF-1 pathway activity, and downstream metabolic signalling.

This category includes CJC-1295 (no DAC), a GRF(1-29) analogue that produces a shorter, more physiologically pulsatile GH-release pattern, and Tesamorelin, one of the most clinically researched GHRH analogues, studied for both GH/IGF-1 pathway effects and visceral fat distribution in specific patient populations.

For in vitro research use only. Compounds in this category are not for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compounds in growth research

Stacks containing growth compounds

Explore all curated multi-compound bundles View all 10 research stacks →

Frequently asked — growth research

What compounds does Velox Peptides supply for growth research?
Velox Peptides supplies 2 research compounds in this category: CJC-1295 wo DAC, Tesamorelin. All are HPLC-verified and supplied with a batch certificate of analysis.
Are these peptides for human use?
No. All compounds supplied by Velox Peptides are strictly for in vitro research use by qualified researchers. They are not medicinal products and are not for human or veterinary consumption.
How are research peptides supplied?
Research compounds are supplied as lyophilised (freeze-dried) powders in sterile vials for reconstitution with bacteriostatic water prior to research use. See our reconstitution calculator for concentration and volume calculations.
Is a certificate of analysis supplied?
Yes. A batch-specific certificate of analysis documenting HPLC purity, mass spectrometry confirmation, and appearance is supplied with every order. Previous batch CoAs are available in our CoA library.
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.